Tweet by Chris Palmer, MD semaglutide mitigates mouse model of Alzheimer’s Posted byJoseph Thornton MDSeptember 26, 2023Posted inBlog Chris Palmer, MD @ChrisPalmerMD Semaglutide ameliorates cognition and glucose metabolism dysfunction in a mouse model of Alzheimer’s disease. Addressing metabolic dysfunction improved memory and learning and reduced plaques and tangles. Human trials underway. #BrainEnergy sciencedirect.com/science/articl… 9/26/23, 2:57 PM Joseph Thornton Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related Published by Joseph Thornton MD Teacher, Clinical Supervisor, [AIdvisor] Retired Clinical Associate Professor, Psychiatry, University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts